Cutaneous allodynia is more frequent in chronic migraine, and its presence and severity seems to be more associated with the duration of the disease
- PMID: 28355322
- DOI: 10.1590/0004-282X20170015
Cutaneous allodynia is more frequent in chronic migraine, and its presence and severity seems to be more associated with the duration of the disease
Abstract
Objective: To evaluate cutaneous allodynia among patients with chronic and episodic migraine in a tertiary headache clinic.
Methods: 80 subjects with episodic migraine and 80 with chronic migraine were assessed in a tertiary hospital. The 12-item Allodynia Symptom Checklist/Brazil questionnaire was applied to classify subjects according to the presence and severity of cutaneous allodynia.
Results: Cutaneous allodynia was identified in 81.3% of the episodic migraine group and 92.5% of the chronic migraine group (p = 0.03). No increased association could be attributed to chronic migraine when adjusted by years with disease (PR = 1.12; 95%CI = 0.99 to 1.27; p = 0.06). The groups also did not differ in the severity of allodynia, and severe presentation was the most frequent.
Discussion: Both groups seemed to be similarly affected in the cephalic and extracephalic regions, with the same severity.
Conclusion: Cutaneous allodynia is more frequent in chronic migraine, and its presence and severity seems to be more associated with the duration of the disease.
Similar articles
-
Cutaneous allodynia in patients with episodic migraine.Neurol Sci. 2013 Aug;34(8):1397-402. doi: 10.1007/s10072-012-1249-9. Epub 2012 Nov 23. Neurol Sci. 2013. PMID: 23179186
-
Cephalic cutaneous allodynia in children and adolescents with migraine of short duration: A retrospective cohort study.Cephalalgia. 2019 Jan;39(1):61-67. doi: 10.1177/0333102418776018. Epub 2018 May 6. Cephalalgia. 2019. PMID: 29732930
-
Cutaneous allodynia as predictor for treatment response in chronic migraine: a cohort study.J Headache Pain. 2023 Aug 30;24(1):118. doi: 10.1186/s10194-023-01651-9. J Headache Pain. 2023. PMID: 37644420 Free PMC article. Clinical Trial.
-
Central sensitisation and cutaneous allodynia in migraine: implications for treatment.CNS Drugs. 2004;18(6):337-42. doi: 10.2165/00023210-200418060-00001. CNS Drugs. 2004. PMID: 15089101 Review.
-
Allodynia in migraine: frequent random association or unavoidable consequence?Expert Rev Neurother. 2009 Mar;9(3):395-408. doi: 10.1586/14737175.9.3.395. Expert Rev Neurother. 2009. PMID: 19271948 Review.
Cited by
-
CGRP Administration Into the Cerebellum Evokes Light Aversion, Tactile Hypersensitivity, and Nociceptive Squint in Mice.Front Pain Res (Lausanne). 2022 Apr 25;3:861598. doi: 10.3389/fpain.2022.861598. eCollection 2022. Front Pain Res (Lausanne). 2022. PMID: 35547239 Free PMC article.
-
Perceived fear and exercise difficulty in patients with migraine and their association with psychosocial factors: a cross-sectional study.PeerJ. 2025 May 12;13:e19342. doi: 10.7717/peerj.19342. eCollection 2025. PeerJ. 2025. PMID: 40386225 Free PMC article.
-
The mechanism and potential therapeutic target of piezo channels in pain.Front Pain Res (Lausanne). 2024 Sep 27;5:1452389. doi: 10.3389/fpain.2024.1452389. eCollection 2024. Front Pain Res (Lausanne). 2024. PMID: 39398533 Free PMC article. Review.
-
Impact of chronic migraine attacks and their severity on the endogenous μ-opioid neurotransmission in the limbic system.Neuroimage Clin. 2019;23:101905. doi: 10.1016/j.nicl.2019.101905. Epub 2019 Jun 18. Neuroimage Clin. 2019. PMID: 31279240 Free PMC article. Clinical Trial.
-
An underrepresented majority: A systematic review utilizing allodynic criteria to examine the present scarcity of discrete animal models for episodic migraine.Cephalalgia. 2021 Mar;41(3):404-416. doi: 10.1177/0333102420966984. Epub 2020 Nov 1. Cephalalgia. 2021. PMID: 33131303 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials